Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charu Aggarwal

Showing results (121-130 of 170) with videos related to

Pageof 17
Sort By:
Head & Neck|December 16, 2020
Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapyRyan M Carey, David Shimunov, Gregory S Weinstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2022
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCharu Aggarwal, Nabil F Saba, Alain Algazi, et al.
American Journal of Clinical Oncology|November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant ChemoimmunotherapyCole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
Iscience|May 27, 2022
Contrasting behavior between the three human monocyte subsets in dengue pathophysiologyDeepti Maheshwari, Keshav Saini, Prabhat Singh, et al.
Oral Oncology|May 1, 2021
Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgeryChristina M Yver, David Shimunov, Gregory S Weinstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2019
Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 StudyEdward B Garon, Matthew D Hellmann, Naiyer A Rizvi, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2019
A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the OropharynxSamuel Swisher-McClure, John N Lukens, Charu Aggarwal, et al.
Clinical Lung Cancer|January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab ConsolidationAdam Barsouk, Cole Friedes, Michelle Iocolano, et al.
Journal of Virology|September 15, 2021
Immunophenotyping and Transcriptional Profiling of Human Plasmablasts in DengueCharu Aggarwal, Keshav Saini, Elluri Seetharami Reddy, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancerStephen J Bagley, Shawn Kothari, Charu Aggarwal, et al.
Pageof 17

Showing results (121-130 of 170) with videos related to

Sort By:
Pageof 17
Head & Neck|December 16, 2020
Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapyRyan M Carey, David Shimunov, Gregory S Weinstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2022
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCharu Aggarwal, Nabil F Saba, Alain Algazi, et al.
American Journal of Clinical Oncology|November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant ChemoimmunotherapyCole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
Iscience|May 27, 2022
Contrasting behavior between the three human monocyte subsets in dengue pathophysiologyDeepti Maheshwari, Keshav Saini, Prabhat Singh, et al.
Oral Oncology|May 1, 2021
Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgeryChristina M Yver, David Shimunov, Gregory S Weinstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2019
Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 StudyEdward B Garon, Matthew D Hellmann, Naiyer A Rizvi, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2019
A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the OropharynxSamuel Swisher-McClure, John N Lukens, Charu Aggarwal, et al.
Clinical Lung Cancer|January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab ConsolidationAdam Barsouk, Cole Friedes, Michelle Iocolano, et al.
Journal of Virology|September 15, 2021
Immunophenotyping and Transcriptional Profiling of Human Plasmablasts in DengueCharu Aggarwal, Keshav Saini, Elluri Seetharami Reddy, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancerStephen J Bagley, Shawn Kothari, Charu Aggarwal, et al.
Pageof 17